These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1758554)

  • 21. Giant right atrial thrombosis associated with Hickman catheter.
    Kula S; Saygili A; Tunaoglu SF; Olgunturk R
    Heart; 2003 Oct; 89(10):1252. PubMed ID: 12975437
    [No Abstract]   [Full Text] [Related]  

  • 22. A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction.
    Little MA; Walshe JJ
    Am J Kidney Dis; 2002 Jan; 39(1):86-91. PubMed ID: 11774106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unusual complication of central venous catheter in hemodialysis.
    Di Iorio BR; Mondillo F; Bortone S; Nargi P; Capozzi M; Spagnuolo T; Cucciniello E; Bellizzi V
    Blood Purif; 2005; 23(6):446-9. PubMed ID: 16155377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of intensive versus standard hemodialysis central venous catheter dysfunction protocol using rt-PA: a quality assurance initiative.
    Wilson JA; Mossop P; Soroka SD; Dipchand C; Drost S; Sheehy N; Tennankore K
    J Vasc Access; 2016; 17(2):143-50. PubMed ID: 26847735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Venous occlusion after catheterization of both subclavian veins for hemodialysis].
    Ocharán J; Pérez P; Miguélez JL; Aguilera L
    An Med Interna; 1997 Dec; 14(12):647. PubMed ID: 9518035
    [No Abstract]   [Full Text] [Related]  

  • 26. Cross-talk between inflammation,coagulation/fibrinolysis and vascular access in hemodialysis patients.
    Costa E; Rocha S; Rocha-Pereira P; Castro E; Reis F; Teixeira F; Miranda V; Do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    J Vasc Access; 2008; 9(4):248-53. PubMed ID: 19085894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters.
    Castner D
    Nephrol Nurs J; 2001 Aug; 28(4):403-4, 407-10. PubMed ID: 12143462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial.
    Haire WD; Atkinson JB; Stephens LC; Kotulak GD
    Thromb Haemost; 1994 Oct; 72(4):543-7. PubMed ID: 7878629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant tissue plasminogen activator for central venous access device occlusion.
    Hooke C
    J Pediatr Oncol Nurs; 2000 Jul; 17(3):174-8. PubMed ID: 10944865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical management of a hemodialysis catheter-induced right atrial thrombus.
    Lalor PF; Sutter F
    Curr Surg; 2006; 63(3):186-9. PubMed ID: 16757370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Right atrial thrombus as a complication of a temporary haemodialysis catheter--a potentially avoidable complication.
    Dreyer G; Bingham C
    Nephrol Dial Transplant; 2005 Feb; 20(2):474-5. PubMed ID: 15673710
    [No Abstract]   [Full Text] [Related]  

  • 32. Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.
    Ponce D; Mendes M; Silva T; Oliveira R
    Artif Organs; 2015 Sep; 39(9):741-7. PubMed ID: 25894244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catheter-Directed Low-Dose Tissue Plasminogen Activator for Treatment of Right Atrial Thrombus Caused by a Central Venous Catheter.
    Orgeron GM; Pollard JL; Pourmalek P; Sloane PJ
    Pharmacotherapy; 2015 Oct; 35(10):e153-8. PubMed ID: 26497485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant tissue plasminogen activator to declot dialysis fistulas.
    Boobes Y; al Hassan H; Neglen P; Obeid K; Denour N
    J Nephrol; 1997; 10(2):107-10. PubMed ID: 9238617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of aortic thrombosis after umbilical catheterization with tissue plasminogen activator.
    Ahluwalia JS; Kelsall AW; Diederich S; Rennie JM
    Acta Paediatr; 1994 Nov; 83(11):1215-7. PubMed ID: 7841741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tip Design of Hemodialysis Catheters Influences Thrombotic Events and Replacement Rate.
    Petridis C; Nitschke M; Lehne W; Smith E; Goltz JP; Lehnert H; Meier M
    Eur J Vasc Endovasc Surg; 2017 Feb; 53(2):262-267. PubMed ID: 27876561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoration of flow following haemodialysis catheter thrombus. Analysis of rt-PA infusion in tunnelled dialysis catheters.
    Davies J; Casey J; Li C; Crowe AV; McClelland P
    J Clin Pharm Ther; 2004 Dec; 29(6):517-20. PubMed ID: 15584939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteplase as hemodialysis catheter locking solution and spurious hyperphosphatemia.
    Sombolos K; Bamichas G; Hatsiou V; Fragidis S; Rizos A; Natse T; Fytili C
    J Vasc Access; 2011; 12(3):269. PubMed ID: 21218384
    [No Abstract]   [Full Text] [Related]  

  • 39. Superior vena cava (SVC) thrombosis: diagnosis and follow up by transesophageal echocardiography (TEE).
    Freih M; Saba S
    J Am Soc Echocardiogr; 2005 Mar; 18(3):280-1. PubMed ID: 15746722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Right atrial thrombosis associated with hemodialysis catheter: first description of recurrence in a poorly understood problem.
    Asmarats L; Fernández-Palomeque C; Martínez-Riutort JM; Bethencourt A
    J Thromb Thrombolysis; 2015 Feb; 39(2):254-7. PubMed ID: 25030331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.